Chronic rhinosinusitis: an under-researched epidemic

Table 3 Utility, DALY, and economic comparisons between CRS, asthma and DM

Chronic disease	Health state utility (SF-6D derived)	Disability weight	Annual direct health care cost	Annual indirect cost
CRS	0.65 [9]	Not defined	$3,143/patient [23]	^a$10,500/patient [10]
Asthma	0.70 [19]	^b0.009 [24]	$4,081/patient [25]	^d$5,846/patient [25]
Asthma	0.70 [19]	^c0.027 [24]	$4,081/patient [25]	^d$5,846/patient [25]
DM	0.68 [20]	0.015 [26]	$7,900/patient [27]	$3,920/patient [27]

(Note: all values were adjusted with an inflation calculator to reflect 2014 USD).
DALY, disability adjusted life years; CRS, chronic rhinosinusitis; DM, diabetes mellitus; SF, short-form.
^aThis indirect cost reflects patients with refractory CRS who were recruited from a tertiary level centre and likely over-estimates the mean indirect cost for all patients with CRS.
^bThis is the disability weight for ‘controlled asthma’.
^cThis is the disability weight for ‘partially controlled asthma’.
^dThis indirect cost reflects patients with severe asthma and likely overestimates the mean indirect cost for all patients with asthma.

ISSN: 1916-0216